JS207

· Shanghai Junshi Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for JS207, covering 2025-04-25 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: JS207 Combination Therapy in Triple-negative Breast Cancer [Phase 2]